Media

The Neuron Clinic Becomes First Neurology Office to Implement Positrigo’s NeuroLF for Point-of-Care Brain PET Imaging

Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders

Kivu Bioscience Appoints Sophia Randolph, M.D., Chief Medical Officer

Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051

10 Years of HelloBetter: Psychological AI Companion Marks First Step Toward Integrated Mental Health Care

Oncopeptides to host Capital Markets Update featuring leading global experts in Multiple Myeloma

Doctrin receives MDR certification under class IIa

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress

Kivu Bioscience Presents Preclinical Data for KIVU-107 Demonstrating Potent and Durable Anti-Tumor Activity and a Wide Therapeutic Index at World ADC San Diego 2025

Oncopeptides – Journal of Cancer Research and Clinical Oncology: Exceptional long-term responses to Pepaxti